Quarterly report pursuant to Section 13 or 15(d)

Shareholders Equity and Capital Stock (Details 7)

v3.21.1
Shareholders Equity and Capital Stock (Details 7)
3 Months Ended
Mar. 31, 2021
USD ($)
$ / shares
shares
Exercise price $1.00  
Exercise price | $ / shares $ 1.00
Number of warrants | shares 13,062,878
Remaining contractual life (years) 6 months
Aggregate Intrinsic Value | $ $ 653,144
Expiry Sep. 25, 2021
Exercise price $0.75  
Exercise price | $ / shares $ 0.75
Number of warrants | shares 8,038,000
Remaining contractual life (years) 1 year 3 months 18 days
Aggregate Intrinsic Value | $ $ 1,406,650,000
Expiry Aug. 04, 2022
Exercise price $1.35  
Exercise price | $ / shares $ 1.35
Number of warrants | shares 16,930,530
Remaining contractual life (years) 2 years 9 months 18 days
Aggregate Intrinsic Value | $ $ 0
Expiry Feb. 04, 2024
Exercise price $1.10  
Exercise price | $ / shares $ 1.10
Number of warrants | shares 38,031,408
Remaining contractual life (years) 1 year 8 months 12 days
Aggregate Intrinsic Value | $ $ 2,059,794,000